logo
Search orAI Icon𝛼SK
ENTITY

Mira Pharmaceuticals (MIRA US)

26
Analysis
Health Care • United States
Mira Pharmaceuticals, Inc. operates as a biotech company. The Company develops prescription drug to target the CB1 and CB2 receptors for chronic pain and anxiety without the impurities of marijuana or its side effects such as increased appetite and paranoia. Mira Pharmaceuticals serves customers worldwide.
more
bullish•Mira Pharmaceuticals
•30 Jun 2025 23:00•Issuer-paid

MIRA: Data Shows Weight Drop Without Muscle Loss

MIRA Pharmaceuticals(MIRA) Company Sponsored Research Report

Logo
Share
bullish•Mira Pharmaceuticals
•26 Jun 2025 00:00•Issuer-paid

MIRA: New Data Shows Promise from New Acquisition

MIRA Pharmaceuticals(MIRA) Company Sponsored Research Report

Logo
Share
bullish•Mira Pharmaceuticals
•19 Jun 2025 00:00•Issuer-paid

MIRA: Journal Acceptance Adds Validation

MIRA Pharmaceuticals(MIRA) Company Sponsored Research Report

Logo
Share
bullish•Mira Pharmaceuticals
•16 May 2025 01:00•Issuer-paid

MIRA: Breakthroughs Continue as Financial Results Released

MIRA Pharmaceuticals(MIRA) Company Sponsored Research Report

Logo
Share
bullish•Mira Pharmaceuticals
•06 May 2025 23:00•Issuer-paid

MIRA: Breakthrough Results for Pain Treatment

MIRA Pharmaceuticals(MIRA) Company Sponsored Research Report

Logo
Share

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7

x